情报工程
情報工程
정보공정
Technology Intelligence Engineering
2015年
4期
21-31
,共11页
治部真里%李颖(译)%曾文(编审)
治部真裏%李穎(譯)%曾文(編審)
치부진리%리영(역)%증문(편심)
AMED%日本医疗研究开发机构%日本版NIH%NIH%药物%指标%研究开发%循证政策
AMED%日本醫療研究開髮機構%日本版NIH%NIH%藥物%指標%研究開髮%循證政策
AMED%일본의료연구개발궤구%일본판NIH%NIH%약물%지표%연구개발%순증정책
AMED%Japan Agency for Medical Research and Development%A Japanese version of the NIH%National Institutes of Health%Pharmaceuticals%Indicators%Research and development%Evidence based policy
AMED（日本版NIH）及其制药企业，政策制定与战略规划需要循证。为此，本研究尝试基于新的指标体系进行制药行业的现状俯瞰与未来预测。本篇面向与在研药物及药物密切关联的专利，针对此专利的审查官和申请人所引用的专利及文献，并着眼于被引专利的技术领域，分析贯穿专利申请过程的知识流。
AMED（日本版NIH）及其製藥企業，政策製定與戰略規劃需要循證。為此，本研究嘗試基于新的指標體繫進行製藥行業的現狀俯瞰與未來預測。本篇麵嚮與在研藥物及藥物密切關聯的專利，針對此專利的審查官和申請人所引用的專利及文獻，併著眼于被引專利的技術領域，分析貫穿專利申請過程的知識流。
AMED（일본판NIH）급기제약기업，정책제정여전략규화수요순증。위차，본연구상시기우신적지표체계진행제약행업적현상부감여미래예측。본편면향여재연약물급약물밀절관련적전리，침대차전리적심사관화신청인소인용적전리급문헌，병착안우피인전리적기술영역，분석관천전리신청과정적지식류。
For the sake of providing evidences that contribute to policy making or strategy planning in AMED (a Japanese version of the NIH) and pharmaceutical companies, we tried an overview and future prospects of pharmaceutical industry based on new indicators. Here we show the knowledge flows of the pharmaceutical innovation system, focusing on the patents related with pipelines and drugs, the patents and NPLs cited on the patents by patent examiners and applicants, and the technical fields of cited patents.
